{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:36:17Z","timestamp":1780547777102,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ctro.2024.100764","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T17:45:22Z","timestamp":1710351922000},"page":"100764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-6616","authenticated-orcid":false,"given":"Ivica","family":"Ratosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0493","authenticated-orcid":false,"given":"Angel","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ciervide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Garc\u00eda-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen-Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"de la Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Fernandez-Leton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100764_b0005","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Radiotherapy to regional nodes in early breast cancer: Individual-patient-data meta-analysis of 14,324 women in 16 trials. In Press. Lancet 2023;6736:1\u201313. doi:10.1016\/S0140-6736(23)01082-6.","DOI":"10.1016\/S0140-6736(23)01082-6"},{"key":"10.1016\/j.ctro.2024.100764_b0010","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in radiation oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0015","doi-asserted-by":"crossref","unstructured":"Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, et al. Understanding breast cancer complexity to improve patient outcomes: The St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol 2023;xxx. doi:10.1016\/j.annonc.2023.08.017.","DOI":"10.1016\/j.annonc.2023.08.017"},{"key":"10.1016\/j.ctro.2024.100764_b0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.breast.2023.04.006","article-title":"Hypofractionation: the standard for external beam breast irradiation","volume":"69","author":"Brunt","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ctro.2024.100764_b0025","doi-asserted-by":"crossref","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† Ann Oncol 2023. doi:10.1016\/j.annonc.2023.11.016.","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"10.1016\/j.ctro.2024.100764_b0030","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ctro.2024.100764_b0035","first-page":"1","article-title":"Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer","volume":"41","author":"Montero","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2011.06.026","article-title":"First results of the randomised UK FAST trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015)","volume":"100","author":"Agrawal","year":"2011","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0045","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-Year results of FAST: a randomized controlled trial of 5-Fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0050","first-page":"1","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"6736","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2024.100764_b0055","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0167-8140(22)02477-X","article-title":"OC-0101 first results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects","volume":"170","author":"Wheatley","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.213","article-title":"Physician- and patient-reported outcomes of the MC1635 phase 3 trial of Ultrahypofractionated versus moderately Hypofractionated adjuvant radiation therapy after breast-conserving surgery","author":"Laughlin","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100764_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102568","article-title":"Ultra-Hypofractionation for whole-breast irradiation in early breast cancer: interim analysis of a prospective study","volume":"10","author":"Sigaudi","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ctro.2024.100764_b0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/0284186X.2023.2267170","article-title":"Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre","volume":"62","author":"Sauvage","year":"2023","journal-title":"Acta Oncol (madr)"},{"key":"10.1016\/j.ctro.2024.100764_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.breast.2020.12.009","article-title":"Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost","volume":"55","author":"Van Hulle","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.ctro.2024.100764_b0080","doi-asserted-by":"crossref","first-page":"e2300010","DOI":"10.1200\/GO.23.00010","article-title":"Looking Back: international practice patterns in breast radiation oncology from a case-based survey across 54 countries during the first surge of the COVID-19 pandemic","volume":"9","author":"Oladeru","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0085","article-title":"Adoption of Ultrahypofractionated radiation therapy in patients with breast cancer","volume":"7","author":"Corrigan","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2019.04.010","article-title":"ESTRO consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer","volume":"137","author":"Kaidar-Person","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2015.06.010","article-title":"Recommendations from GEC ESTRO breast cancer working group (I): Target definition and target delineation for accelerated or boost Partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery","volume":"115","author":"Strnad","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2015.12.006","article-title":"Recommendations from GEC ESTRO breast cancer working group (II): Target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery","volume":"118","author":"Major","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0110","unstructured":"Cancer Institute N. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 2017. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"10.1016\/j.ctro.2024.100764_b0115","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ijrobp.2017.01.229","article-title":"Highly accelerated irradiation in 5 Fractions (HAI-5): feasibility in elderly women with early or locally advanced breast cancer","volume":"98","author":"Monten","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100764_b0120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jgo.2019.04.007","article-title":"Accelerating adjuvant breast irradiation in women over 65 years: matched case analysis comparing a 5-fractions schedule with 15 fractions in early and locally advanced breast cancer","volume":"10","author":"Van Hulle","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/0284186X.2020.1747638","article-title":"Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions","volume":"59","author":"Van Hulle","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2020.07.007","article-title":"Health-related quality of life after accelerated breast irradiation in five fractions: a comparison with fifteen fractions","volume":"151","author":"Van Hulle","year":"2020","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.prro.2022.01.017","article-title":"Prone breast and lymph node irradiation in 5 or 15 Fractions: a randomized 2 \u00d7 2 design Comparing dosimetry, acute toxicity, and set-up errors","volume":"12","author":"Vakaet","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/WWBF1044","article-title":"One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT","volume":"27","author":"Brunt","year":"2023","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ctro.2024.100764_b0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results \u2013 interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0150","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/S0167-8140(23)08819-9","article-title":"PD-0230 one week hypofractionated breast radiotherapy acute toxicity with SIB and regional nodal irradiation","volume":"182","author":"Potdevin-Stein","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0155","article-title":"Is FAST FORWARD the way Forward in radiotherapy for locally advanced breast cancer - Learnings from the COVID pandemic","author":"Giridhar","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ctro.2024.100764_b0160","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijrobp.2023.06.215","article-title":"Largest real-world data of regional nodal irradiation using ultra-Hypofractionated 5-Fraction adjuvant radiation therapy for breast cancer from a single Institute in India","volume":"117","author":"Pathak","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100764_b0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2020.04.012","article-title":"Comparison of nodal Target volume definition in breast cancer radiation therapy according to RTOG versus ESTRO atlases: a Practical review from the TransAtlantic radiation oncology network (TRONE)","volume":"107","author":"Loganadane","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100764_b0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clon.2021.04.016","article-title":"Five-fraction radiotherapy for breast cancer: FAST-Forward to implementation","volume":"33","author":"Brunt","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctro.2024.100764_b0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.breast.2010.03.003","article-title":"Hypofractionated breast radiotherapy: financial and economic consequences","volume":"19","author":"Lievens","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.ctro.2024.100764_b0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.radonc.2022.02.033","article-title":"Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): a feasibility study","volume":"170","author":"Mulliez","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100764_b0185","article-title":"Trends in utilization and Medicare spending on short-course radiotherapy for breast and prostate cancer: an Episode-based analysis from 2015\u20132019","author":"Patel","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T22:05:10Z","timestamp":1724969110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"alternative-id":["S2405630824000417"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100764","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100764"}}